Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Ascletis's ASC35, a once-monthly GLP-1/GIP dual agonist, entered IND in early 2026
Increasing payer support and reimbursement coverage, enabling broader patient access and long-term market growth Government Initiatives Supporting the Obesity GLP-1 Market As obesity is increasingly recognized as a chronic, high-burden disease, government initiatives are playing a key role in supporting the obesity GLP-1 market
The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity activity weekly, along with strength exercises on two or more days, to support metabolic health
At Smart Choice Medical Clinic, we dont believe in one-size-fits-all medicine
US$ 25.34
US$ 25.15
US$ 25.28
US$ 24.98
US$ 28.14
US$ 26.42
US$ 27.78
US$ 22.72
